Multiparametric MRI plus PSMA-PET to Monitor Active Surveillance
One in three men on Active Surveillance eventually stops, not because their cancer
worsened, but because of fear. A new study suggests better imaging could change that. Researchers found that combining mpMRI with PSMA-PET nearly doubled detection rates for clinically significant prostate cancer, and helped 18% of patients avoid an unnecessary biopsy. keep reading
